Curran Daniel J. 4
4 · Xilio Therapeutics, Inc. · Filed Jun 17, 2024
Insider Transaction Report
Form 4
Curran Daniel J.
Director
Transactions
- Award
Stock Option (right to buy)
2024-06-14+25,000→ 25,000 totalExercise: $1.02Exp: 2034-06-13→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option was granted on June 14, 2024 and will vest as to 100% of the shares underlying the option on the earlier of (i) June 14, 2025 and (ii) the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.